Stephanie Gaillard

No bio available.

Financial relationships

  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    AstraZeneca
    Date added: 
    08/29/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Blueprint
    Date added: 
    08/29/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Compugen
    Date added: 
    08/29/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Curio Science
    Date added: 
    08/29/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    GenenTech/Roche
    Date added: 
    08/29/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    GOG/Clovis
    Date added: 
    08/29/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Immunogen
    Date added: 
    08/29/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    lovance
    Date added: 
    08/29/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Lumanity
    Date added: 
    08/29/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    NCTN
    Date added: 
    08/29/2023

Pages

Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond